Amy Burley

4PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.

Nicola Maciocia, Malika Hoekx, Ciaran Acuna

|Aug 12, 2024
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy.

Emmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak

|Jul 24, 2024
TP53 mutations in urothelial carcinoma: not all one and the same†.

Alexis R Barr, Amy Burley, Anna Wilkins

|May 04, 2022
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia.

Paul M Maciocia, Patrycja A Wawrzyniecka, Nicola C Maciocia

Pageof 1